Dr. Boris Rubashkin, MD

Dr. Rubashkin practices at BHC- Behavioral Health Consultants, Inc in Houston, Texas.

Dr. Rubashkin's NPI, 1750473047, was assigned on September 28, 2006. Dr. Rubashkin graduated from St Petersburg State Pediatric Medicine Academy in 1969. Dr. Rubashkin's Texas license number on file is G1763.

Dr. Rubashkin's primary practice is BHC- Behavioral Health Consultants, Inc, at 9525 Katy Fwy, Houston, TX 77024 in Harris County. The practice phone is (713) 463-9449.

Dr. Rubashkin's primary practice is BHC- Behavioral Health Consultants, Inc in Houston, Texas. The medical group on file is BHC Houston. Dmand AI also links Dr. Rubashkin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubashkin practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Rubashkin's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Rubashkin's licenses on file in 2 states: Texas and Minnesota.

Dmand AI lists ADHD, adjustment disease, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia and intellectual and developmental disabilities among the conditions Dr. Rubashkin treats.

CMS data shows 1,104 Medicare services from Dr. Rubashkin across 2 procedure codes in 2024, for 278 Medicare patients. Medicare paid $90,133 for them. Every service was in an office.

CMS counts 278 Medicare patients who saw Dr. Rubashkin in 2024. The largest group is under 65, with 171 patients. 64% of them have high blood pressure, and 63% have high cholesterol. 76% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rubashkin's median patient age at 47, with 54% women.

In 2024, Dr. Rubashkin wrote 14,329 Medicare Part D claims for 508 patients. 91% of them were for generic drugs. CMS names the drug for 14,191 of them, across 101 drugs with 11 or more claims each, at $2,484,787 in total drug cost. In 2023, CMS named 15,564 claims across 102 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rubashkin for performance year 2024, reported individually. Dr. Rubashkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rubashkin as offering telehealth.

CMS Open Payments shows 632 general payments to Dr. Rubashkin from 28 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 89% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $1,837.

Dr. Rubashkin graduated from St Petersburg State Pediatric Medicine Academy in 1969.

Dr. Rubashkin is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.